Article Listing - EMEA warning over SSRIs, SNRIs in children

INTERFERON ALFA-N3 AND AIDS

6 April 1992

Researchers at the Walter Reed Army Institute of Research and at Interferon Sciences have commenced Phase I trials with the...

GERMAN POLICY UNDER FIRE

6 April 1992

German Health Minister Gerda Hasselfeldt has accused the leading German doctors' organization, the Hartmannbund, of political agitation, after it held...

SANOFI 1991 NET INCOME UP 12.1%

6 April 1992

For France's Elf Sanofi, earnings progressed satisfactorily in 1991 despite the adverse operating environment (the world economic situation including the...

WORLD MARKET FOR BIO-DRUGS

6 April 1992

Biopharmaceuticals will be the single fastest-growing segment of the total pharmaceutical market worldwide in the 1990s, with average annual growth...

PFIZER'S DIFLUCAN

6 April 1992

Prophylactic administration of Pfizer's Diflucan (fluconazole) to recipients of autologous bone marrow transplants reduces the incidence of both systemic and...

GENZYME AND CYSTIC FIBROSIS

6 April 1992

Genzyme is to exercise its option to buy rights to Neozyme's cystic fibrosis protein replacement therapeutic program, under the terms...

BLOOD BANKING AND PLASMA PRODUCTS

6 April 1992

The world market for blood banking and plasma products was valued at $2.5 billion in 1990, and is expected to...

GLAXO FRANCE CHIEF QUITS

6 April 1992

Edwin Nathan, president of Glaxo France and of the group's Belgian and Luxembourg companies, has announced his departure from the...

ARAB PHARMA COOPERATION

6 April 1992

The executive board of the Union of Arab Druggists, meeting in Cairo, has established a new system of cooperation in...

GLOBAL MARKETS AND FACTORS FOR SUCCESS

6 April 1992

As the geographical borders between pharmaceutical markets begin to disappear, so do the differences among the critical success factors for...

Showing 94431-94440 of 95353 articles

Go to beginningPreviousNextGo to end